All Roll Calls
Yes: 52 • No: 50
WyomingHB 2822025 General SessionHouse
AN ACT relating to ad valorem taxation; establishing a rebuttable presumption in favor of acquisition value for specified real property; clarifying the use, disclosure and confidentiality of sworn statements for specified real property; providing definitions; making conforming amendments; requiring rulemaking; and providing for effective dates.
Sponsored By: Tony Locke (Republican)
Failed
Your PRIA Score
Score Hidden
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & Cosponsors
Sponsor
Tony Locke
Republican • House
Cosponsors
Bill Allemand
Republican • House
Dalton Banks
Republican • House
John Bear
Republican • House
Marlene Brady
Republican • House
Joel Guggenmos
Republican • House
Scott Heiner
Republican • House
Steve Johnson
Republican • House
Christopher Knapp
Republican • House
Jayme Lien
Republican • House
Ann Lucas
Republican • House
Ken Pendergraft
Republican • House
Rachel Rodriguez-Williams
Republican • House
Scott Smith
Republican • House
Clarence Styvar
Republican • House
Reuben Tarver
Republican • House
Robert Wharff
Republican • House
Bob Ide
Republican • Senate
Dan Laursen
Republican • Senate
Scott Smith
Republican • House
Roll Call Votes
Senate vote • 2/28/2025
S COW:Failed 8-21-2-0-0
Yes: 8 • No: 21
Senate vote • 2/24/2025
S03 - Revenue:Recommend Amend and Do Pass 3-2-0-0-0
Yes: 3 • No: 2
House vote • 2/6/2025
H 3rd Reading:Passed 35-25-2-0-0
Yes: 35 • No: 25
House vote • 1/30/2025
H03 - Revenue:Recommend Do Pass 6-2-1-0-0
Yes: 6 • No: 2
Actions Timeline
S COW:Failed 8-21-2-0-0
2/28/2025SenateS03 - Revenue:Recommend Amend and Do Pass 3-2-0-0-0
2/24/2025SenateS Placed on General File
2/24/2025SenateS Introduced and Referred to S03 - Revenue
2/20/2025SenateS Received for Introduction
2/7/2025SenateH 3rd Reading:Passed 35-25-2-0-0
2/6/2025HouseH 2nd Reading:Passed
2/5/2025HouseH COW:Passed
2/4/2025HouseH03 - Revenue:Recommend Do Pass 6-2-1-0-0
1/30/2025HouseH Placed on General File
1/30/2025HouseH Introduced and Referred to H03 - Revenue
1/27/2025HouseBill Number Assigned
1/23/2025H Received for Introduction
1/23/2025House
Bill Text
Engrossed
Introduced
Related Bills
SF 167 — AN ACT relating to professions and occupations; authorizing the board of chiropractic examiners to obtain criminal background checks as specified; requiring applicants for licensure and licensees subject to investigation and disciplinary action by the board of chiropractic examiners to submit fingerprints and other necessary information for a criminal background check; specifying applicability; requiring rulemaking; and providing for effective dates.
SF 171 — AN ACT relating to cities and towns; amending requirements for conducting a boundary survey of cities and towns as specified; and providing for an effective date.
SF 107 — AN ACT relating to miscellaneous contracts and actions; providing that contractual covenants not to compete are void; providing exceptions; specifying requirements for covenants not to compete for physicians; specifying applicability; and providing for an effective date.
SF 104 — AN ACT relating to the probate code; amending maximum values for certain proceedings relating to the probate of estates; clarifying the effect of certain disclaimers of property; and providing for an effective date.
SF 53 — AN ACT relating to trade and commerce; authorizing the secretary of state to administratively cancel trademarks, service marks and trade names as specified; providing the right to appeal administrative cancellations; and providing for an effective date.
HB 164 — AN ACT relating to professions and occupations; authorizing prescribers to prescribe medications for off-label indication as specified; authorizing pharmacists to dispense medications for off-label indication as specified; providing prescribers and pharmacists immunity from disciplinary action as specified; providing definitions; requiring rulemaking; and providing for an effective date.